Dishman Pharmaceuticals & Chemicals announcements, page 2

Mar 2017

16 Mar · Disclosure
Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Janmejay R Vyas (opens in a new tab)
8 Mar · Analysts
Analysts/Institutional Investor Meet/Con. Call Updates (opens in a new tab)
8 Mar · Updates
In reference to Company's intimation dated March 08, 2017, intimation regarding fire took place at one of the units (Unit No.7) at Company's Bavla facility, this is to further inform that there will be no impact on the production in any of the other units located at said Bavla facility. (opens in a new tab)
8 Mar · Updates
In reference to our today's intimation regarding fire took place at one of the units (Unit No.7) at our Bavla facility, this is to further inform that there will be no impact on the production .... (opens in a new tab)
8 Mar · Disclosure
Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Janmejay R Vyas (opens in a new tab)
8 Mar · Updates
There was a fire incident at one of the units (Unit No.7) at the Company's Bavla facility on March 07, 2017 late evening and it had been brought under control. Health and safety of the people is always prime concern and that has been achieved. The Company also do not see any major financial impact due to the incident. Moreover, the Company has an insurance policy for the assets damage and the loss of profit. (opens in a new tab)
8 Mar · Updates
Intimation is hereby given that there was a fire incident at one of the units (Unit No.7) at our Bavla facility yesterday late evening and it had been brought under control. Health and .... (opens in a new tab)
2 Mar · Disclosure
Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Janmejay R Vyas (opens in a new tab)
1 Mar · Updates
Reg.: Intimation regarding Redemption of Non-Convertible Debenture (NCD). As per the terms of the NCD, on 18th February, 2017, Company has made full payment of Principal Repayment/Redemption .... (opens in a new tab)

Feb 2017

Jan 2017

20 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
13 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, .... (opens in a new tab)

Dec 2016

Dishman Pharmaceuticals & Chemicals (Delisted) share news and announcements

Dishman Pharmaceuticals & Chemicals share news and announcements

Mar 2017

Feb 2017

Jan 2017

Dec 2016

Nov 2016

Oct 2016

Sep 2016